HEADER BIOSYNTHETIC PROTEIN 06-APR-09 3GZ7 TITLE CRYSTAL STRUCTURE OF PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE TITLE 2 (NP_888398.1) FROM BORDETELLA BRONCHISEPTICA AT 2.15 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BORDETELLA BRONCHISEPTICA; SOURCE 3 ORGANISM_COMMON: ALCALIGENES BRONCHISEPTICUS; SOURCE 4 ORGANISM_TAXID: 518; SOURCE 5 GENE: BB1853, NP_888398.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS NP_888398.1, PUTATIVE ANTIBIOTIC BIOSYNTHESIS MONOOXYGENASE, KEYWDS 2 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 3 PROTEIN STRUCTURE INITIATIVE, PSI-2, ANTIBIOTIC BIOSYNTHESIS KEYWDS 4 MONOOXYGENASE; DIMERIC ALPHA-BETA BARREL, BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3GZ7 1 REMARK SEQADV REVDAT 3 24-JUL-19 3GZ7 1 REMARK LINK REVDAT 2 25-OCT-17 3GZ7 1 REMARK REVDAT 1 21-APR-09 3GZ7 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE ANTIBIOTIC BIOSYNTHESIS JRNL TITL 2 MONOOXYGENASE (NP_888398.1) FROM BORDETELLA BRONCHISEPTICA JRNL TITL 3 AT 2.15 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 12610 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 617 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 879 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE SET COUNT : 39 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1577 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.73000 REMARK 3 B22 (A**2) : 1.17000 REMARK 3 B33 (A**2) : -0.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.228 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.198 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.139 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.315 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1665 ; 0.017 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1135 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2259 ; 1.626 ; 1.940 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2737 ; 1.008 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 201 ; 6.093 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 87 ;28.267 ;23.218 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 270 ;15.206 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;10.429 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 232 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1898 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 358 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 285 ; 0.191 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1154 ; 0.199 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 735 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 895 ; 0.084 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 104 ; 0.186 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 9 ; 0.283 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 31 ; 0.311 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.283 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1114 ; 2.318 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 400 ; 0.720 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1611 ; 3.084 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 715 ; 5.381 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 648 ; 6.849 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A -1 A 96 4 REMARK 3 1 B -1 B 96 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1338 ; 0.330 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1338 ; 1.400 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. CITRATE (CIT) MOLECULES ARE MODELED BASED ON REMARK 3 THE CRYSTALLIZATION CONDITION. 4. THERE ARE UNEXPLAINED ELECTRON REMARK 3 DENSITIES FOUND NEAR NON-CRYSTALLOGRAPHIC 2-FOLD BETWEEN ILE 5 REMARK 3 OF A AND B MOLECULES. THEY ARE NOT MODELED. REMARK 4 REMARK 4 3GZ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052490. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.64 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97966,0.97946 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12610 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 29.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.16300 REMARK 200 R SYM (I) : 0.16300 REMARK 200 FOR THE DATA SET : 4.3720 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.61900 REMARK 200 R SYM FOR SHELL (I) : 0.61900 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27.5000% POLYETHYLENE GLYCOL 6000, REMARK 280 0.1M CITRIC ACID PH 4.64, NANODROP, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.84600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.90350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.84600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.90350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE REMARK 300 ASSIGNMENT OF A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 120 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -18 REMARK 465 GLY A -17 REMARK 465 SER A -16 REMARK 465 ASP A -15 REMARK 465 LYS A -14 REMARK 465 ILE A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 MSE B -18 REMARK 465 GLY B -17 REMARK 465 SER B -16 REMARK 465 ASP B -15 REMARK 465 LYS B -14 REMARK 465 ILE B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 81 CG CD OE1 OE2 REMARK 470 GLN A 88 OE1 NE2 REMARK 470 GLU B 81 CG CD OE1 OE2 REMARK 470 GLN B 88 OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 73 O HOH A 131 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 64 -65.51 -100.59 REMARK 500 VAL B 64 -64.87 -109.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 97 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT B 97 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390479 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. DBREF 3GZ7 A 1 96 UNP Q7WL96 Q7WL96_BORBR 1 96 DBREF 3GZ7 B 1 96 UNP Q7WL96 Q7WL96_BORBR 1 96 SEQADV 3GZ7 MSE A -18 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLY A -17 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 SER A -16 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 ASP A -15 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 LYS A -14 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 ILE A -13 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS A -12 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS A -11 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS A -10 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS A -9 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS A -8 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS A -7 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLU A -6 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 ASN A -5 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 LEU A -4 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 TYR A -3 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 PHE A -2 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLN A -1 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLY A 0 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 MSE B -18 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLY B -17 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 SER B -16 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 ASP B -15 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 LYS B -14 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 ILE B -13 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS B -12 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS B -11 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS B -10 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS B -9 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS B -8 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 HIS B -7 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLU B -6 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 ASN B -5 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 LEU B -4 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 TYR B -3 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 PHE B -2 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLN B -1 UNP Q7WL96 EXPRESSION TAG SEQADV 3GZ7 GLY B 0 UNP Q7WL96 EXPRESSION TAG SEQRES 1 A 115 MSE GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS GLU SEQRES 2 A 115 ASN LEU TYR PHE GLN GLY MSE ILE GLN GLU ILE ALA SER SEQRES 3 A 115 ILE LEU VAL GLN PRO GLY ARG GLU ALA ASP PHE GLU ALA SEQRES 4 A 115 GLY VAL ALA GLN ALA ARG PRO LEU PHE MSE ARG ALA ARG SEQRES 5 A 115 GLY CYS HIS GLY VAL ALA LEU HIS ARG SER ILE GLU ALA SEQRES 6 A 115 PRO GLN ARG TYR THR LEU VAL VAL ASP TRP GLU THR VAL SEQRES 7 A 115 ASP ASN HIS MSE VAL ASP PHE ARG GLN SER ALA ASP PHE SEQRES 8 A 115 GLN GLU TRP ARG LYS LEU VAL GLY GLU CYS PHE ALA GLU SEQRES 9 A 115 PRO PRO GLN VAL HIS HIS GLU GLN LYS VAL LEU SEQRES 1 B 115 MSE GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS GLU SEQRES 2 B 115 ASN LEU TYR PHE GLN GLY MSE ILE GLN GLU ILE ALA SER SEQRES 3 B 115 ILE LEU VAL GLN PRO GLY ARG GLU ALA ASP PHE GLU ALA SEQRES 4 B 115 GLY VAL ALA GLN ALA ARG PRO LEU PHE MSE ARG ALA ARG SEQRES 5 B 115 GLY CYS HIS GLY VAL ALA LEU HIS ARG SER ILE GLU ALA SEQRES 6 B 115 PRO GLN ARG TYR THR LEU VAL VAL ASP TRP GLU THR VAL SEQRES 7 B 115 ASP ASN HIS MSE VAL ASP PHE ARG GLN SER ALA ASP PHE SEQRES 8 B 115 GLN GLU TRP ARG LYS LEU VAL GLY GLU CYS PHE ALA GLU SEQRES 9 B 115 PRO PRO GLN VAL HIS HIS GLU GLN LYS VAL LEU MODRES 3GZ7 MSE A 1 MET SELENOMETHIONINE MODRES 3GZ7 MSE A 30 MET SELENOMETHIONINE MODRES 3GZ7 MSE A 63 MET SELENOMETHIONINE MODRES 3GZ7 MSE B 1 MET SELENOMETHIONINE MODRES 3GZ7 MSE B 30 MET SELENOMETHIONINE MODRES 3GZ7 MSE B 63 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 30 16 HET MSE A 63 8 HET MSE B 1 8 HET MSE B 30 16 HET MSE B 63 8 HET CIT A 97 13 HET CIT B 97 13 HETNAM MSE SELENOMETHIONINE HETNAM CIT CITRIC ACID FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 CIT 2(C6 H8 O7) FORMUL 5 HOH *143(H2 O) HELIX 1 1 ARG A 14 ARG A 31 1 18 HELIX 2 2 THR A 58 VAL A 64 1 7 HELIX 3 3 SER A 69 GLY A 80 1 12 HELIX 4 4 GLU A 81 PHE A 83 5 3 HELIX 5 5 ARG B 14 ALA B 25 1 12 HELIX 6 6 ALA B 25 ARG B 31 1 7 HELIX 7 7 THR B 58 VAL B 64 1 7 HELIX 8 8 SER B 69 GLY B 80 1 12 HELIX 9 9 GLU B 81 PHE B 83 5 3 SHEET 1 A 9 ILE A 2 LEU A 9 0 SHEET 2 A 9 ARG A 49 TRP A 56 -1 O TRP A 56 N ILE A 2 SHEET 3 A 9 CYS A 35 SER A 43 -1 N GLY A 37 O ASP A 55 SHEET 4 A 9 GLN B 88 LEU B 96 -1 O VAL B 95 N LEU A 40 SHEET 5 A 9 ILE B 2 LEU B 9 -1 N SER B 7 O GLN B 88 SHEET 6 A 9 ARG B 49 TRP B 56 -1 O TRP B 56 N ILE B 2 SHEET 7 A 9 CYS B 35 SER B 43 -1 N HIS B 41 O THR B 51 SHEET 8 A 9 GLN A 88 LEU A 96 -1 N LEU A 96 O LEU B 40 SHEET 9 A 9 ILE A 2 LEU A 9 -1 N ILE A 5 O HIS A 90 LINK C GLY A 0 N MSE A 1 1555 1555 1.32 LINK C MSE A 1 N ILE A 2 1555 1555 1.33 LINK C PHE A 29 N AMSE A 30 1555 1555 1.34 LINK C PHE A 29 N BMSE A 30 1555 1555 1.33 LINK C AMSE A 30 N ARG A 31 1555 1555 1.32 LINK C BMSE A 30 N ARG A 31 1555 1555 1.33 LINK C HIS A 62 N MSE A 63 1555 1555 1.33 LINK C MSE A 63 N VAL A 64 1555 1555 1.33 LINK C GLY B 0 N MSE B 1 1555 1555 1.33 LINK C MSE B 1 N ILE B 2 1555 1555 1.32 LINK C PHE B 29 N AMSE B 30 1555 1555 1.33 LINK C PHE B 29 N BMSE B 30 1555 1555 1.32 LINK C AMSE B 30 N ARG B 31 1555 1555 1.32 LINK C BMSE B 30 N ARG B 31 1555 1555 1.33 LINK C HIS B 62 N MSE B 63 1555 1555 1.33 LINK C MSE B 63 N VAL B 64 1555 1555 1.34 SITE 1 AC1 11 GLU A 4 LEU A 52 HIS A 62 ARG A 67 SITE 2 AC1 11 GLN A 68 PHE A 72 TRP A 75 ARG A 76 SITE 3 AC1 11 PHE A 83 PRO A 87 VAL A 89 SITE 1 AC2 10 GLU B 4 LEU B 52 HIS B 62 ARG B 67 SITE 2 AC2 10 PHE B 72 TRP B 75 ARG B 76 PHE B 83 SITE 3 AC2 10 PRO B 87 VAL B 89 CRYST1 103.692 55.807 40.658 90.00 97.28 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009644 0.000000 0.001232 0.00000 SCALE2 0.000000 0.017919 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024795 0.00000